Skip to main content
. 2021 May 6;2021:9928282. doi: 10.1155/2021/9928282

Table 4.

Enrichment results of target pathway.

Id KEGG pathway P value Targets Count
Hsa04668 TNF signaling pathway 2.84E − 14 IL6, Jun, MAPK8, IL1 B, CASP3, MAPK1, CCL2, AKT1, FOS, PTGS2, TNF, MMP9 12
Hsa04620 Toll-like receptor signaling pathway 2.12E − 09 IL6, Jun, MAPK8, CXCL8, IL1 B, MAPK1, AKT1, FOS, TNF 9
Hsa04010 MAPK signaling pathway 7.62E − 09 Jun, MAPK8, EGF, IL1B, CASP3, MAPK1, AKT1, FOS, HRAS, TNF, TP53 11
Hsa04068 FoxO signaling pathway 1.38E − 08 IL10, IL6, MAPK8, EGF, PTEN, MAPK1, AKT1, HRAS, SIRT1 9
Hsa04066 HIF-1 signaling pathway 3.24E − 08 IL6, EGF, NOS3, MAPK1, AKT1, HIF1A, MTOR, VEGFA 8
Hsa04621 NOD-like receptor signaling pathway 3.48E − 08 IL6, MAPK8, CXCL8, IL1B, MAPK1, CCL2, TNF 7
Hsa04370 VEGF signaling pathway 5.88E − 08 Src, NOS3, MAPK1, AKT1, PTGS2, HRAS, VEGFA 7
Hsa04151 PI3K-Akt signaling pathway 1.81E − 06 IL6, EGF, NOS3, PTEN, MAPK1, AKT1, HRAS, TP53, MTOR, VEGFA 10
Hsa04931 Insulin resistance 1.81E − 06 IL6, MAPK8, NOS3, PTEN, AKT1, TNF, MTOR 7
Hsa04150 mTOR signaling pathway 5.04E − 05 Pten, MAPK1, AKT1, TNF, MTOR 5